Delivery Order SPE2DB20D1004-SPE2DB23FF3L0

Award Date 3/1/23
Potential Completion Date 3/2/23
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Loteprednol Etabonate 0.5% eye drops in 10ml vials, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,361.57 contract has a firm fixed price and was awarded on November 2, 2021, with a completion date of November 3, 2021. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,845.34 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% eyedrops (10 ml). This is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,324.32 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 15 ml, with a performance period ending on February 1, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $1,866.34 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of loteprednol etabonate 0.5% eye drops, a prescription medication, and has an ultimate completion date of September 20, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation for providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.23 delivery order contract is for the supply of the pharmaceutical product Loteprednol Etabonate 0.5% Ophthalmic Drops, 5 ML. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,449.86 Firm Fixed Price Delivery Order is for the supply of 4,564,730,207 units of Loteprednol Etabonate 0.5% ophthalmic drops, with a performance period ending on May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Single-Award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF3L0
    Delivery Order

This federal contract award is for the delivery of loteprednol etabonate 0.5% eye drops, in 5 ml quantities, to the Defense Logistics Agency (DLA). The $2,143.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2023, with an ultimate completion date of March 2, 2023. This contract is not designated as a set-aside.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA, valued up to $999,999,999.00, as well as the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs enable Amerisourcebergen to efficiently provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and other critical care materials, to support military, veterans, and other federal healthcare programs.

Generated 2/27/25, 10:10 AM